Limitations, agreements, and source contact

Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee

true

restrictive Agreement

false

limitations And Caveats

description

Endpoint for association of clinical benefit response with donor/recipient KIR ligand matching status is not evaluable due to 0 complete responders. Correlative laboratory objectives are irrelevant due to ineffectiveness of study regimen.

point Of Contact

email

gelle005@umn.edu

organization

University of Minnesota, Dept. Ob/Gyn

phone

612-626-3111

title

Melissa Geller, M.D.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice